Showing results (801-810 of 5,688) with videos related to

Sort By:
Pageof 569
The Oncologist|February 14, 2013
Adjuvant therapy with zoledronic acid in patients with breast cancer: a systematic review and meta-analysisAntonis Valachis, Nikolaos P Polyzos, Robert E Coleman, et al.
The Oncologist|February 23, 2013
Breast implant-associated ALCL: a unique entity in the spectrum of CD30+ lymphoproliferative disordersSara K Story, Michael K Schowalter, Larisa J Geskin
The Oncologist|January 25, 2013
A patient-centered approach to counseling patients with head and neck cancer undergoing human papillomavirus testing: a clinician's guideAmy Chu, Eric Genden, Marshall Posner, et al.
The Oncologist|February 28, 2013
The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experienceS Yousuf Zafar, Jeffrey M Peppercorn, Deborah Schrag, et al.
The Oncologist|April 12, 2012
Trastuzumab for small HER-2+ breast cancer: small tumor, big decisionRoisin M Connolly, Aditya Bardia
The Oncologist|December 25, 2012
Oncology drug development and approval of systemic anticancer therapy by the U.S. Food and Drug AdministrationRobert E Martell, David Sermer, Kenneth Getz, et al.
The Oncologist|December 25, 2012
Elderly postmenopausal patients with breast cancer are at increased risk for distant recurrence: a tamoxifen exemestane adjuvant multinational study analysisWillemien van de Water, Caroline Seynaeve, Esther Bastiaannet, et al.
The Oncologist|May 9, 2012
Proteasome inhibition and combination therapy for non-Hodgkin's lymphoma: from bench to bedsideAnthony R Mato, Tatyana Feldman, André Goy
The Oncologist|September 17, 2014
Efficacy and safety of the FOLFOX4 regimen versus doxorubicin in Chinese patients with advanced hepatocellular carcinoma: a subgroup analysis of the EACH studyShukui Qin, Ying Cheng, Jun Liang, et al.
The Oncologist|September 19, 2014
Bone-targeting radiopharmaceuticals for the treatment of bone-metastatic castration-resistant prostate cancer: exploring the implications of new dataCharles J Ryan, Philip J Saylor, Jason J Everly, et al.
Pageof 569